Literature DB >> 30860558

Dupilumab (Dupixent) for Asthma.

.   

Abstract

Entities:  

Year:  2019        PMID： 30860558     DOI： 10.1001/jama.2019.0080

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  A role for IL-33-activated ILC2s in eosinophilic vasculitis.

Authors:  Maya E Kotas; Jérémie Dion; Steven Van Dyken; Roberto R Ricardo-Gonzalez; Claire J Danel; Camille Taillé; Luc Mouthon; Richard M Locksley; Benjamin Terrier
Journal:  JCI Insight       Date:  2021-06-22

2.  Dupilumab as a novel steroid-sparing treatment for hypereosinophilic syndrome.

Authors:  Xiaoman Du; Yudi Chen; Jianmin Chang; Xuelin Sun; Yue Zhang; Meng Zhang; Marcus Maurer; Yanming Li; Zuotao Zhao; Xunliang Tong
Journal:  JAAD Case Rep       Date:  2022-03-17

Review 3.  The perplexing role of RAGE in pulmonary fibrosis: causality or casualty?

Authors:  Timothy N Perkins; Tim D Oury
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.